Health Technology Assessment Standards and Practices: How Does Canada Compare with Other Countries?
Download Full Article SummaryArticle Brief
OPEN ACCESS
Download Full Article
CHP blogazine
-
PMPRB’s Selective Use of Undefined Data Is Intended to Further its Misleading Narrative
Nigel Rawson, PhD - Background - The Patented Medicine Prices Review Board (PMPRB) i »
Opinions
-
Patients’ access to innovative medicines should be an election issue
Nigel Rawson and Beth Vanstone | Hamilton Spectator | Sept 9, 2021 »
-
Appeal court exposes PMPRB abuse of power and bias on drug pricing
Nigel Rawson and John Adams | Financial Post | August 18, 2021 »
-
We no longer need the PMPRB
Brett Skinner and Nigel Rawson | The Hamilton Spectator | JULY 13, 2021 »
News
-
COMING SOON: New look for CHP Journal
CHP Readers, We will soon be relaunching Canadi »
-
GET 50% OFF ARTICLES, SUBSCRIPTIONS, MEMBERSHIPS. LIMITED TIME OFFER.
We have reduced our regular prices from $40 per ar »
-
JOURNALISTS SUBSCRIBE FREE
Accredited media representatives subscribe free of »
Information and ideas for a better health system
- Copyright © 2021 Canadian Health Policy Institute (CHPI)
- •
- XML Sitemap
- •
- Valid XHTML